| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/11/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 06/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
4
| SKYLER JAY S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/08/2023 |
4
| MARCUS JOEL S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/08/2023 |
4
| Lerner Teena (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/08/2023 |
4
| Kanter Stacy J. (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/08/2023 |
4
| Funtleyder Leslie D. (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/12/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 16.5% stake in Applied Therapeutics, Inc. |
| 05/08/2023 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 10% stake in Applied Therapeutics, Inc. |
| 05/05/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/28/2023 |
SC 13D/A
| Shendelman Shoshana reports a 13.3% stake in APPLIED THERAPEUTICS, INC. |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/23/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/23/2023 |
8-K
| Quarterly results |
| 02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 10% stake in Applied Therapeutics, Inc. |
|